60NANB22D201
Project Grant
Overview
Grant Description
Purpose: This application requests cancer research equipment for the following areas:
1. Microscopic imaging
2. Lead development optimization
3. Transgenic and gene targeting
4. Cryo-electron microscopy & DNA repair
5. Cancer pathology scanning
6. Clinical pharmacology
7. Metabolic nutrition
8. Essential basic science
Activities to be performed: KUCC will procure $5.0 million in new equipment to refresh the shared use laboratories supporting the cancer center's three research programs:
1. Cancer biology
2. Cancer prevention and control
3. Drug discovery, delivery, and experimental therapeutics
Expected outcomes: These new instruments will help provide the optimal environment to focus the power of precision medicine, basic science inquiry, drug discovery and development, and behavioral interventions to decrease cancer incidence, morbidity, and mortality.
Intended beneficiaries: Residents of the state of Kansas (105 counties) as well as the 18 neighboring counties of western Missouri will benefit from the enhanced research made possible by the investment in this equipment. These residents are served by KUCC, as it is the only academic cancer center in this region.
Subrecipient activities: No subawards with this application.
1. Microscopic imaging
2. Lead development optimization
3. Transgenic and gene targeting
4. Cryo-electron microscopy & DNA repair
5. Cancer pathology scanning
6. Clinical pharmacology
7. Metabolic nutrition
8. Essential basic science
Activities to be performed: KUCC will procure $5.0 million in new equipment to refresh the shared use laboratories supporting the cancer center's three research programs:
1. Cancer biology
2. Cancer prevention and control
3. Drug discovery, delivery, and experimental therapeutics
Expected outcomes: These new instruments will help provide the optimal environment to focus the power of precision medicine, basic science inquiry, drug discovery and development, and behavioral interventions to decrease cancer incidence, morbidity, and mortality.
Intended beneficiaries: Residents of the state of Kansas (105 counties) as well as the 18 neighboring counties of western Missouri will benefit from the enhanced research made possible by the investment in this equipment. These residents are served by KUCC, as it is the only academic cancer center in this region.
Subrecipient activities: No subawards with this application.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Kansas City,
Kansas
66160-8500
United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Analysis Notes
Amendment Since initial award the End Date has been extended from 09/30/23 to 09/30/24.
University Of Kansas Medical Center Research Institute was awarded
Cancer Research Equipment Precision Medicine Drug Discovery
Project Grant 60NANB22D201
worth $5,000,000
from the National Institute of Standards and Technology in October 2022 with work to be completed primarily in Kansas City Kansas United States.
The grant
has a duration of 2 years and
was awarded through assistance program 11.617 Congressionally-Identified Projects.
Status
(Ongoing)
Last Modified 10/2/23
Period of Performance
10/1/22
Start Date
9/30/24
End Date
Funding Split
$5.0M
Federal Obligation
$0.0
Non-Federal Obligation
$5.0M
Total Obligated
Activity Timeline
Transaction History
Modifications to 60NANB22D201
Additional Detail
Award ID FAIN
60NANB22D201
SAI Number
60NANB22D201_2
Award ID URI
EXE
Awardee Classifications
Other
Awarding Office
1333ND DEPT OF COMMERCE NIST
Funding Office
1333ND DEPT OF COMMERCE NIST
Awardee UEI
YXJGGNC5J269
Awardee CAGE
3Q5T1
Performance District
KS-03
Senators
Jerry Moran
Roger Marshall
Roger Marshall
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Scientific and Technical Research and Services, National Institute of Standards and Technology, Commerce (013-0500) | Other advancement of commerce | Grants, subsidies, and contributions (41.0) | $5,000,000 | 100% |
Modified: 10/2/23